{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:09:43Z","timestamp":1791043783662,"version":"4.1.0"},"reference-count":33,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,4]]},"abstract":"\nObject<\/jats:title>\nThe survival of patients with high-grade gliomas remains unfavorable. Mibefradil, a T-type calcium channel inhibitor capable of synchronizing dividing cells at the G1 phase, has demonstrated potential benefit in conjunction with chemotherapeutic agents for gliomas in in vitro studies. In vivo study of mibefradil and radiosurgery is lacking. The authors used an intracranial C6 glioma model in rats to study tumor response to mibefradil and radiosurgery.<\/jats:p><\/jats:sec>\n\nMethods<\/jats:title>\nTwo weeks after implantation of C6 cells into the animals, each rat underwent MRI every 2 weeks thereafter for 8 weeks. After tumor was confirmed on MRI, the rats were randomly assigned to one of the experimental groups. Tumor volumes were measured on MR images. Experimental Group 1 received 30 mg\/kg of mibefradil intraperitoneally 3 times a day for 1 week starting on postoperative day (POD) 15; Group 2 received 8 Gy of cranial radiation via radiosurgery delivered on POD 15; Group 3 underwent radiosurgery on POD 15, followed by 1 week of mibefradil; and Group 4 received mibefradil on POD 15 for 1 week, followed by radiosurgery sometime from POD 15 to POD 22. Twenty-seven glioma-bearing rats were analyzed. Survival was compared between groups using Kaplan-Meier methodology.<\/jats:p><\/jats:sec>\n\nResults<\/jats:title>\nMedian survival in Groups 1, 2, 3, and 4 was 35, 31, 43, and 52 days, respectively (p = 0.036, log-rank test). Two animals in Group 4 survived to POD 60, which is twice the expected survival of untreated animals in this model. Analysis of variance and a post hoc test indicated no tumor volume differences on PODs 15 and 29. However, significant volume differences were found on POD 43; mean tumor volumes for Groups 1, 2, 3, and 4 were 250, 266, 167, and 34 mm3<\/jats:sup>, respectively (p = 0.046, ANOVA). A Cox proportional hazards regression test showed survival was associated with tumor volume on POD 29 (p = 0.001) rather than on POD 15 (p = 0.162). In vitro assays demonstrated an appreciable and dose-dependent increase in apoptosis between 2- and 7-\u03bcM concentrations of mibefradil.<\/jats:p><\/jats:sec>\n\nConclusions<\/jats:title>\nMibefradil response is schedule dependent and enhances survival and reduces glioblastoma when combined with ionizing radiation.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2012.11.jns121087","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T15:08:08Z","timestamp":1354288088000},"page":"830-837","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery"],"prefix":"10.3171","volume":"118","author":[{"given":"Jason P.","family":"Sheehan","sequence":"first","affiliation":[{"name":"Departments of Neurological Surgery and"},{"name":"Radiation Oncology, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britney","family":"Popp","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"},{"name":"Radiation Oncology, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns121087","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","article-title":"Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas","volume":"94","author":"Barth","year":"2009"},{"key":"b2-jns121087","series-title":"Bioessays","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/bies.950170605","article-title":"Calcium signaling and cell proliferation","volume":"17","author":"Berridge","year":"1995"},{"key":"b3-jns121087","series-title":"Mol Pharmacol","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1124\/mol.62.2.210","article-title":"The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms","volume":"62","author":"Bertolesi","year":"2002"},{"key":"b4-jns121087","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.1993.11.7.1316","article-title":"Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma","volume":"11","author":"Dinapoli","year":"1993"},{"key":"b5-jns121087","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00195612","article-title":"A new glioma model in rat: the C6 spheroid implantation technique permeability and vascular characterization","volume":"4","author":"Farrell","year":"1987"},{"key":"b6-jns121087","series-title":"Mol Cell Biochem","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-008-9791-8","article-title":"Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1beta-induced beta-cell apoptosis","volume":"315","author":"Fei","year":"2008"},{"key":"b7-jns121087","series-title":"Cell Calcium","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ceca.2006.04.014","article-title":"The pharmacology and regulation of T type calcium channels: new opportunities for unique therapeutics for cancer","volume":"40","author":"Gray","year":"2006"},{"key":"b8-jns121087","series-title":"Pharmacol Res","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/phrs.2001.0836","article-title":"Selectivity of blocking of low-versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma\u2014glioma NG 108-15 cells","volume":"44","author":"Himmel","year":"2001"},{"key":"b9-jns121087","series-title":"Brain Res Brain Res Rev","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainresrev.2004.03.001","article-title":"Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas","volume":"45","author":"Jansen","year":"2004"},{"issue":"Suppl 3","key":"b10-jns121087","series-title":"Neuro Oncol","first-page":"iii108","article-title":"Mibefradil, a novel therapy for glioblastoma multiforme: interlaced therapy in a murine model","volume":"13","author":"Keir","year":"2011"},{"key":"b11-jns121087","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijrobp.2008.10.025","article-title":"Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation","volume":"73","author":"Khan","year":"2009"},{"key":"b12-jns121087","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1227\/00006123-199208000-00012","article-title":"Radiobiology of radiosurgery: Part I. The normal rat brain model","volume":"31","author":"Kondziolka","year":"1992"},{"key":"b13-jns121087","series-title":"Life Sci","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0024-3205(85)90120-1","article-title":"Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin","volume":"36","author":"Lee","year":"1985"},{"key":"b14-jns121087","series-title":"Cancer Invest","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/07357907.2011.568565","article-title":"Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation","volume":"29","author":"Li","year":"2011"},{"key":"b15-jns121087","series-title":"J Cardiovasc Pharmacol","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00005344-199904000-00012","article-title":"Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells","volume":"33","author":"Lijnen","year":"1999"},{"key":"b16-jns121087","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0006-8993(89)91282-1","article-title":"Electrophyisiological and biochemical characterization of a continuous human astrocytoma cell line with many properties of well-differentiated astrocytes","volume":"486","author":"Lonneth","year":"1989"},{"key":"b17-jns121087","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1074\/jbc.M008215200","article-title":"Molecular and functional characterization of a family of rat brain T-type calcium channels","volume":"276","author":"McRory","year":"2001"},{"key":"b18-jns121087","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.280.2.157","article-title":"Life-threatening interaction of mibefradil and \u03b2-blockers with dihydropyridine calcium channel blockers","volume":"280","author":"Mullins","year":"1998"},{"key":"b19-jns121087","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.05.062","article-title":"Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma","volume":"72","author":"Narayana","year":"2008"},{"key":"b20-jns121087","series-title":"Graefes Arch Clin Exp Ophthalmol","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00417-004-0886-y","article-title":"Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells","volume":"242","author":"Nebe","year":"2004"},{"key":"b21-jns121087","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bjp.0701140","article-title":"Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl\u2212 channels in macrovascular endothelial cells","volume":"121","author":"Nilius","year":"1997"},{"key":"b22-jns121087","series-title":"Cell Calcium","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ceca.2004.07.002","article-title":"Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells","volume":"37","author":"Panner","year":"2005"},{"key":"b23-jns121087","series-title":"Cell Calcium","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ceca.2006.04.029","article-title":"T-type calcium channels and tumor proliferation","volume":"40","author":"Panner","year":"2006"},{"key":"b24-jns121087","series-title":"J Physiol","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1469-7793.1998.093bz.x","article-title":"K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation","volume":"510","author":"Rouzaire-Dubois","year":"1998"},{"key":"b25-jns121087","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1476-5381.2012.01908.x","article-title":"Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy","volume":"166","author":"Santoni","year":"2012"},{"key":"b26-jns121087","series-title":"Mol Cancer Res","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1541-7786.MCR-10-0469","article-title":"HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance","volume":"9","author":"Schwartz","year":"2011"},{"key":"b27-jns121087","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3171\/JNS\/2008\/108\/5\/0972","article-title":"Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation","volume":"108","author":"Sheehan","year":"2008"},{"key":"b28-jns121087","series-title":"World J Gastroenterol","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3748\/wjg.14.4984","article-title":"Calcium signaling and T-type calcium channels in cancer cell cycling","volume":"14","author":"Taylor","year":"2008"},{"key":"b29-jns121087","series-title":"Phys Med Biol","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1088\/0031-9155\/54\/17\/017","article-title":"A comprehensive system for dosimetric commissioning and Monte Carlo validation for the small animal radiation research platform","volume":"54","author":"Tryggestad","year":"2009"},{"key":"b30-jns121087","series-title":"Cancer Res","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995"},{"key":"b31-jns121087","series-title":"J Physiol","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1469-7793.2001.0661e.x","article-title":"Blocking swelling-activated chloride current inhibits mouse liver cell proliferation","volume":"532","author":"Wondergem","year":"2001"},{"key":"b32-jns121087","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.ijrobp.2008.04.025","article-title":"High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities","volume":"71","author":"Wong","year":"2008"},{"key":"b33-jns121087","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1476-5381.2012.01852.x","article-title":"Inhibition of T-type Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration","volume":"166","author":"Zhang","year":"2012"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/118\/4\/article-p830.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/118\/4\/article-p830.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/118\/4\/article-p830.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:44:15Z","timestamp":1660499055000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/118\/4\/article-p830.xml"}},"subtitle":["Laboratory investigation"],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2012.11.jns121087","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}